Steris Plc

Research Steris Plc (STE) on Bullrun: valuation model: 3.7% overvalued, market cap USD 20.81B, P/E 26.9, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSTE
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Valuation signal3.7% overvalued
• Market capUSD 20.81B
• P/E26.9
• Dividend yield0.9%
• Financial periodFY2026
• RevenueUSD 5.94B
• Revenue growth8.7%
• Net incomeUSD 782.30M
• Free cash flowUSD 972.40M
• Gross margin44.2%

Valuation Snapshot

Bullrun's latest valuation model marks Steris Plc as 3.7% overvalued; latest market cap is USD 20.81B; P/E is 26.9; dividend yield is 0.9%.

About Steris Plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.

Frequently asked questions

Is Steris Plc overvalued or undervalued?

Bullrun's valuation model currently marks Steris Plc as 3.7% overvalued.

What is Steris Plc's market cap?

Steris Plc's market capitalization is USD 20.81B.

What is Steris Plc's P/E ratio?

Steris Plc's price-to-earnings (P/E) ratio is 26.9.

Does Steris Plc pay a dividend?

Steris Plc has a dividend yield of 0.9%.

What does Steris Plc do?

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.